These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26976971)

  • 21. A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study.
    Saiura A; Yamamoto J; Hasegawa K; Oba M; Takayama T; Miyagawa S; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Makuuchi M; Kokudo N
    Drug Discov Ther; 2014 Feb; 8(1):48-56. PubMed ID: 24647158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial.
    Tsuburaya A; Yoshida K; Kobayashi M; Yoshino S; Takahashi M; Takiguchi N; Tanabe K; Takahashi N; Imamura H; Tatsumoto N; Hara A; Nishikawa K; Fukushima R; Nozaki I; Kojima H; Miyashita Y; Oba K; Buyse M; Morita S; Sakamoto J
    Lancet Oncol; 2014 Jul; 15(8):886-93. PubMed ID: 24954805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a characteristic copy number alteration profile by high-resolution single nucleotide polymorphism arrays associated with metastatic sporadic colorectal cancer.
    González-González M; Fontanillo C; Abad MM; Gutiérrez ML; Mota I; Bengoechea O; Santos-Briz Á; Blanco O; Fonseca E; Ciudad J; Fuentes M; De Las Rivas J; Alcazar JA; García J; Muñoz-Bellvis L; Orfao A; Sayagués JM
    Cancer; 2014 Jul; 120(13):1948-59. PubMed ID: 24668684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective study of S-1 versus tegafur/uracil and oral leucovorin in patients with metastatic colorectal cancer.
    Shibahara K; Yamamoto M; Kakeji Y; Sakata H; Maehara Y
    Anticancer Res; 2008; 28(3B):1779-83. PubMed ID: 18630459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of the Postoperative Adjuvant Chemotherapy with UFT/LV or Capecitabine for Stage III Colorectal Cancer].
    Maruyama T; Yasuda K; Sako A; Ueda K; Okumura M
    Gan To Kagaku Ryoho; 2016 Jan; 43(1):69-72. PubMed ID: 26809528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A retrospective study of UFT and oral leucovorin combination adjuvant chemotherapy for patients over 76 years old with stage III colon cancer].
    Tomizawa K; Hanaoka Y; Toda S; Moriyama J; Matoba S; Kuroyanagi H; Hashimoto M; Udagawa H; Watanabe G
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):881-5. PubMed ID: 23863728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin.
    Tsunoda A; Nakao K; Watanabe M; Matsui N; Tsunoda Y
    Jpn J Clin Oncol; 2010 May; 40(5):412-9. PubMed ID: 20085907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.
    Li J; Xu R; Xu J; Denda T; Ikejiri K; Shen L; Toh Y; Shimada K; Kato T; Sakai K; Yamamoto M; Mishima H; Wang J; Baba H
    Cancer Sci; 2017 Oct; 108(10):2045-2051. PubMed ID: 28763145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life of colorectal cancer patients receiving oral UFT plus leucovorin compared with those with surgery alone.
    Tsunoda A; Nakao K; Tsunoda Y; Watanabe M; Matsui N
    Int J Clin Oncol; 2010 Apr; 15(2):153-60. PubMed ID: 20191299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
    Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
    Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adjuvant chemotherapy for colorectal cancer].
    Akasu T
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):307-12. PubMed ID: 16531709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
    Hasegawa K; Saiura A; Takayama T; Miyagawa S; Yamamoto J; Ijichi M; Teruya M; Yoshimi F; Kawasaki S; Koyama H; Oba M; Takahashi M; Mizunuma N; Matsuyama Y; Watanabe T; Makuuchi M; Kokudo N
    PLoS One; 2016; 11(9):e0162400. PubMed ID: 27588959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (≥75 years) Japanese patients with metastatic colorectal cancer: SGOSG-CR0501 study.
    Matsumoto T; Nishina T; Mizuta M; Tsuji A; Watanabe R; Takahashi I; Watanabe Y; Moriwaki T; Maeba T; Hyodo I
    Int J Clin Oncol; 2015 Feb; 20(1):111-6. PubMed ID: 24553862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of oxaliplatin combined with S-1 and leucovorin (SOL) for Chinese patients with metastatic colorectal cancer.
    Wang ZQ; Zhang DS; Xu N; Luo DY; Deng YH; Wang FH; Luo HY; Qiu MZ; Li YH; Xu RH
    Chin J Cancer; 2016 Jan; 35():8. PubMed ID: 26739998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective study as first-line chemotherapy combined anti-VEGF antibody with fluoropyrimidine for frail patients with unresectable or metastatic colorectal cancer.
    Yoshida M; Goto M; Kii T; Nishitani H; Kawabe S; Kuwakado S; Asaishi K; Miyamoto T; Higuchi K
    Digestion; 2013; 87(1):59-64. PubMed ID: 23343971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study).
    Muro K; Boku N; Shimada Y; Tsuji A; Sameshima S; Baba H; Satoh T; Denda T; Ina K; Nishina T; Yamaguchi K; Takiuchi H; Esaki T; Tokunaga S; Kuwano H; Komatsu Y; Watanabe M; Hyodo I; Morita S; Sugihara K
    Lancet Oncol; 2010 Sep; 11(9):853-60. PubMed ID: 20708966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (Samit) Trial.
    Tsuburaya A; Sakamoto J; Morita S; Kodera Y; Kobayashi M; Miyashita Y; Macdonald JS
    Jpn J Clin Oncol; 2005 Nov; 35(11):672-5. PubMed ID: 16275676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
    Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
    Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur-Uracil Plus Leucovorin Versus Capecitabine.
    Tashiro J; Yamaguchi S; Ishii T; Kondo H; Hara K; Shimizu H; Takemoto K; Suzuki A
    Clin Colorectal Cancer; 2017 Sep; 16(3):e141-e145. PubMed ID: 28216247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Future directions in the adjuvant treatment of colon cancer.
    Mamounas EP; Wieand HS; Jones J; Wickerham DL; Wolmark N
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):44-7. PubMed ID: 9348567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.